According to the results of a study of more than 13,000 patients conducted by a team of scientists from the University of Nottingham, a pill that combines three different medicines could save thousands of lives. The results of this research indicate that the polypill extends the life of people with a history of heart disease.The study is published in the British Medical Journal.Hace two years some British scientists say that a polypill that integrates six drugs could reduce by 80 percent the risk of heart attacks and strokes in people over 55 a os.En the latter study, scientists from Nottingham studied combinations of drugs that lower cholesterol (statins), aspirin, beta blockers and ACE inhibitor that reduces blood sangu nea.El research work is to monitor the evolution of 13,029 patients diagnosed with coronary artery disease that were administered with different combinations of these drugs for seven years. At the end of the study, 2,266 patients had died. The polypill who treated patients with the highest degree of success (83 percent) was a combination of statin drugs, aspirin and beta blockers. The addition of an ACE inhibitor provided greater benefits.The lowest treatment success rate (20 percent) was the administration of mono-therapy, eg beta blockers or inhibitors ACE.Los only authors of the research only studied patients with coronary heart disease, so that we can not conclude from the results of their study that all people over 55 should take a polypill to extend their life. However, some experts believe this type of drug could be used to prevent certain diseases in addition to treat them.